Skip to main content

Interactions between Blastocystis subtype ST4 and gut microbiota in vitro



Blastocystis ST4 is a common protistan parasite of the gastrointestinal tract of humans and a wide range of animals. While it has been suggested that colonization with ST4 is associated with healthy gut microbiota, how ST4 influences the gut microbiota remains poorly studied. This study aimed to examine the interactions between ST4 and several intestinal bacteria using in vitro co-culture systems, and to further investigate the mechanism of interaction and its effect on the epithelial barrier integrity of HT-29 cells.


Seven intestinal bacteria Bacteroides fragilis, Bifidobacterium longum, Bacillus subtilis, Bacteroides vulgatus, Escherichia coli, Enterococcus faecalis, and Lactobacillus brevis were co-cultured with Blastocystis ST4 in vitro. Flow cytometry and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) were used to determine the role of reactive oxygen species (ROS) and bacteria oxidoreductase genes, respectively, in response to Blastocystis co-incubation. Transepithelial electrical resistance (TEER) and flux assays were performed to assess the effect of microbiota representatives on the integrity of the intestinal epithelial barrier.


Co-incubation with Blastocystis ST4 showed a beneficial influence on most intestinal bacteria, while ST4 significantly inhibited the growth of B. vulgatus, a common pathogen in the genus Bacteroides. The decrease in B. vulgatus when co-incubated with Blastocystis ST4 was associated with high levels of ROS and the upregulation of oxidative stress-related genes. Furthermore, co-incubation with Blastocystis ST4 was able to protect the intestinal epithelial barrier from damage by B. vulgatus.


This study demonstrated, for the first time, that Blastocystis ST4 has beneficial effects on intestinal commensal bacteria in vitro, and can inhibit the growth of pathogenic B. vulgatus. Combined with previous microbiome research on ST4, our data suggest that ST4 may be a beneficial commensal.

Graphical Abstract


Blastocystis is a common single-celled intestinal eukaryote that colonizes the gastrointestinal tract of humans and animals. There are an estimated more than 1–2 billion people colonized with Blastocystis worldwide [1]. The clinical significance of Blastocystis is still unclear, although it has been widely studied for more than 100 years [2]. Recent studies reported Blastocystis infection decreases the proportion of beneficial bacterial, such as Bifidobacterium and Lactobacillus [3, 4]. However, the majority of individuals colonized with Blastocystis are asymptomatic and harbor higher gut bacterial diversity and healthy gut microbiota [5, 6]. These discrepancies may be influenced by the complex nature of Blastocystis wherein several genetically distinct subtypes exist [7].

To date, 25 subtypes have been identified in humans and a wide range of animals based on the analysis of small subunit ribosomal RNA (SSU rRNA) gene [8]. Among them, ST1-4 are the predominant subtypes in humans, accounting for more than 90% of human cases [9]. The prevalence of Blastocystis ST4 seems to be influenced by geography, as it is mainly reported in Europe and rarely found in South America, Africa, and Asia [10, 11]. There are only two studies that report on relationships between Blastocystis ST4 and gut microbiota. ST4 colonization was positively associated with the abundance of Sporolactobacillus and Candidatus Carsonella in Swedish travelers [12]. In addition, a higher proportion of beneficial bacteria Akkermansia was observed in Flemish healthy individuals colonized with Blastocystis ST4 [6].

Nourrisson et al. [13] reported that the proportion of Bifidobacterium spp. was decreased in patients with irritable bowel syndrome (IBS) who were colonized with Blastocystis, and lower abundance of Faecalibacterium prausnitzii was observed in healthy Blastocystis-positive individuals, suggesting that Blastocystis may be used as an indicator of microbiota changes associated with intestinal dysbiosis. Nevertheless, Terveer et al. included Blastocystis-positive (ST1 and ST3) donor samples for fecal microbiota transplantation (FMT) treatment of recurrent Clostridium difficile infection (rCDI), and as a result demonstrated that the presence of Blastocystis ST1 and ST3 from donors did not cause any adverse gastrointestinal symptoms or any significant effect on the treatment outcome [14]. However, it is not clear how Blastocystis affects the gut microbial community.

In the current study, we focused on Blastocystis ST4, the most common subtype in the Flemish Gut Flora Project (FGFP) [6], TwinsUK [15], and the American Gut Project (AGP) [16]. We investigated, in vitro, the interactions between Blastocystis ST4 and representative gut microbiota bacteria. Our findings provide valuable insights into the mechanism by which Blastocystis affects the gut microbiota.


Culture of Blastocystis

Two axenized Blastocystis isolates (WR1 and WR2) belonging to subtype 4 were used in this study. Both isolate WR1 and WR2 were originally isolated from healthy Wistar rats during an animal survey at the National University of Singapore (NUS) [17]. Blastocystis ST4 was maintained in 10 ml of pre-reduced Iscove’s modified Dulbecco’s medium (IMDM) (Gibco) supplemented with heat-inactivated 10% horse serum (Gibco). Cultures were incubated under anaerobic conditions in an AnaeroJar (Oxoid) with gas pack (Oxoid) at 37 °C and subcultured every 3–4 days. Blastocystis cell counts were done manually using a hemocytometer (Kova International).

Bacterial strains

A lyophilized stock of the intestinal representative bacteria was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). The commensal bacteria Escherichia coli ATCC 11775, Enterococcus faecalis ATCC 29212, and Bacillus subtilis ATCC 6633 were cultured and maintained in Luria–Bertani (LB) broth and agar (Sigma). Bifidobacterium longum ATCC 15707 was grown and maintained in Bifidus selective medium (BSM) broth and agar (Sigma). Lactobacillus brevis ATCC 14869 was cultivated on deMan, Rogosa and Sharpe (MRS) medium (Sigma). The microorganisms causing opportunistic infections Bacteroides fragilis ATCC 25285 and Bacteroides vulgatus ATCC 8482 were grown in brain heart infusion (BHI) broth (Sigma), and the number of colony-forming units (CFU) of Bacteroides was counted on Trypticase soy agar with defibrinated sheep blood (BD). All the bacteria were cultured at 37 °C. Bacteroides fragilis, B. longum, and B. vulgatus were incubated in a jar equipped with Anaerogen gas packs (Oxoid).

Co-culture experiments

The protocol for co-culture of Blastocystis and bacteria was described in our previous publication [3]. Briefly, Blastocystis and bacteria were washed three times with pre-reduced sterile phosphate-buffered saline (PBS), respectively. Next, 1 × 109 CFU/ml of each bacteria strain was added to 1 × 107 cells/ml of Blastocystis, which were suspended in 1 ml pre-reduced PBS. Controls consisted of only 1 × 107 cells/ml of Blastocystis and only 1 × 109 CFU/ml of bacteria suspended in 1 ml pre-reduced PBS. After incubation for 24 h at 37 °C, the number of Blastocystis cells was determined using a hemocytometer, and the drop plate method was used to determine the number of bacteria CFU. All co-culture experiments were performed in triplicate and repeated at least three times.

ROS staining and flow cytometry

To determine the cellular reactive oxygen species (ROS) content of B. vulgatus after co-culture, BacLight Red (Thermo Fisher) and 2′,7′-dichlorofluorescein diacetate (DCFDA) (Sigma) were used. Specifically, B. vulgatus were stained with BacLight Red at a concentration of 1 μM for 15 min at room temperature before the co-culture experiment, and then the cells were washed twice using pre-reduced PBS at 1000×g for 10 min. After co-culture for 24 h at 37 °C, cells were stained with DCFDA at a concentration of 20 μM for 30 min at 37 °C, and then washed twice in PBS. The cells were run in an Attune Flow Cytometer (Life Technologies) using blue (488 nm) and yellow (561 nm) lasers. Data were analyzed using FlowJo software.

Gene expression analysis using quantitative reverse-transcription polymerase chain reaction (qRT-PCR)

Bacteroides vulgatus mRNA was extracted using the RNeasy Mini Kit (Qiagen, Germany) according to the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized using the iScript cDNA kit (Bio-Rad). All qPCRs were performed with SsoAdvanced™ Universal SYBR Green Supermix (Bio-Rad) on an Applied Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems). qPCR was carried out in a total volume of 20 μl, which consisted of the master mixture and 2 μl of cDNA template. The former contained 10 μl SsoAdvanced™ Universal SYBR Green Supermix (2×), 0.3 mM of each primer, made up to 18 μl with nuclease-free water. The qPCR protocol consisted of denaturing at 95 °C for 10 min, followed by 40 cycles of 95 °C (15 s) and 60 °C (1 min), and the melt curve stage using the instrument default setting. All primers used in the present study are listed (Additional file 1: Table S1).

Culture of HT-29 cell line

The HT-29 cell line is similar to small intestine enterocytes regarding structure and differentiation process, which can better mimic real responses in vivo [18]. HT-29 stock cultures were maintained in T-75 flasks in a humidified incubator with 5% CO2 at 37 °C. Cell cultures were grown in complete Dulbecco’s modified Eagle’s medium (DMEM), consisting of 10% heat-inactivated fetal bovine serum (FBS) (Gibco) and 1% each of sodium pyruvate (Gibco), non-essential amino acids (Gibco), and penicillin–streptomycin (Gibco). Culture health was evaluated using the trypan blue assay and only cultures with > 95% viability were used for the experiments. For transepithelial electrical resistance (TEER) and permeability experiments, cells were grown on Millipore transwell filters with polyester (PET) membranes of 3 μm pore size placed in 24-well tissue culture plates in DMEM with 5% CO2 at 37 °C. In order to synchronize cells before experiments, all cultures were serum-starved overnight in antibiotic-free and serum-free DMEM.

Epithelial resistance

TEER across HT-29 monolayer was measured using Millipore ERS-2 voltohmmeter. HT-29 monolayers were grown on a Millipore transwell system until confluence was reached, and the monolayers were then stimulated for 48 h with 3 mM sodium butyrate in serum-free medium (Sigma-Aldrich). Differentiated HT-29 monolayers were conditioned by 1 × 106 cells/ml Blastocystis and 1 × 109 CFU/ml B. vulgatus in serum-free DMEM for 24 h at 37 °C in anaerobic conditions.

FITC-dextran permeability assay

The flux assay was performed using fluorescein isothiocyanate-conjugated Dextran 4000 (FITC-Dextran) (Sigma). After TEER measurement, the epithelial and basolateral compartments were washed twice with Hank’s balanced salt solution (HBSS) (Thermo Fisher). Next, 400 μl of warm HBSS was added to the basolateral compartments, and 200 μl of 100 μg/ml FITC-Dextran was added to the apical compartments. After incubation at 37 °C for 1 h, 300 μl of HBSS containing the Dextran-FITC at the basolateral compartment was collected and transferred to a black 96-well plate (Nunc). Fluorescence was measured using a Tecan Infinite F200 microplate reader at excitation and emission wavelengths of 492 nm and 518 nm, respectively.

Statistical analysis

Statistical analysis was performed using GraphPad Prism 7 software (GraphPad Software, CA, USA). The unpaired two-tailed Student’s t-test was used to evaluate differences between the two groups. One-way analysis of variance (ANOVA) was used to evaluate experiments involving multiple groups. Graphs show mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.


Intestinal bacteria have a positive growth effect on the number of Blastocystis ST4 cells in vitro

In order to study the interactions between Blastocystis and gut commensal bacteria in vitro, a co-culture system was established as reported previously [3]. This study used two isolates of Blastocystis ST4, WR1 and WR2, which were individually co-cultured with representative intestinal bacteria (B. fragilis, B. longum, B. subtilis, B. vulgatus, E. coli, E. faecalis, and L. brevis). The number of Blastocystis (WR1 and WR2) cells increased significantly when co-incubated with B. longum, E. coli, E. faecalis, and L. brevis (Fig. 1a, b). The positive effects were also observed when ST4-WR2 was co-incubated with B. subtilis (Fig. 1b). The effects of B. fragilis and B. vulgatus on the growth of Blastocystis WR1 and WR2 were comparable to the Blastocystis-only cultures (Fig. 1a, b).

Fig. 1
figure 1

Intestinal bacteria have a positive effect on Blastocystis cell count in vitro. 107 cells of Blastocystis ST4 were co-cultured with 109 CFU of gut bacteria (B. fragilis, B. longum, B. subtilis, B. vulgatus, E. coli, E. faecalis, and L. brevis) in 1 ml of pre-reduced PBS for 24 h at 37 °C. a Blastocystis ST4-WR1 cell count. b Blastocystis ST4-WR2 cell count

Blastocystis ST4 exerts a positive growth effect on some intestinal bacteria in vitro

The CFU count of intestinal representative bacteria was determined after incubation with ST4-WR1 or ST4-WR2. Generally, most bacteria had a higher CFU count when co-cultured with ST4-WR1 and ST4-WR2. Enterococcus faecalis had a significantly higher CFU count when co-incubated with both ST4-WR1 and ST4-WR2 (Fig. 2a). The CFU of L. brevis increased significantly after co-incubation with ST4-WR1 (Fig. 2a). Bacillus subtilis and E. coli had significantly higher CFU count when co-incubated with ST4-WR2 (Fig. 2a). Interestingly, B. vulgatus had a lower CFU count when co-cultured with both ST4-WR1 and ST4-WR2, and a significant difference was observed in ST4-WR1 (Fig. 2a). Representative images of the bacterial colonies on agar plates from the co-incubation assay are shown in Fig. 2b.

Fig. 2
figure 2

Blastocystis ST4 has a positive effect on some intestinal bacteria in vitro. a Most gut bacteria co-cultured with Blastocystis ST4 showed higher CFU count, while the CFU of B. vulgatus was significantly decreased in the presence of Blastocystis ST4-WR1. b Representative plates of colony-forming units (CFU)/ml

Blastocystis ST4 induces oxidative stress on B. vulgatus in vitro

Oxidative stress refers to the imbalance between the production of ROS and the antioxidant capacity of cells [19], which is one of the typical factors that exacerbate shifts of the microbiota thereby yielding dysbiosis [20]. We further investigated whether Blastocystis ST4 affects the viability of B. vulgatus through such a mechanism. We used flow cytometry to detect the ROS content in B. vulgatus (Fig. 3a). Flow cytometry analysis of DCFDA content showed that co-culture with both ST4-WR1 and ST4-WR2 induced a significant increase in DCFDA content in B. vulgatus, indicating the presence of increased cellular ROS (Fig. 3b). In addition, several important genes in response to oxidative stress of B. vulgatus were also analyzed including trxB (thioredoxin-disulfide reductase), trxA (thioredoxin), ahpC (peroxiredoxin), ahpF (alkyl hydroperoxide reductase subunit F), and BVU_RS16335 (ferredoxin). The PCR primers used are specific to B. vulgatus and do not amplify control Blastocystis cDNA (results not shown). Results showed that two of the oxidoreductase genes, trxB and BVU_RS16335, were upregulated when co-cultured with ST4-WR1 (Fig. 4). These results indicate that the decrease of B. vulgatus when co-incubated with Blastocystis ST4 was associated with the high content of ROS and the upregulation of oxidative stress-related genes.

Fig. 3
figure 3

Blastocystis induces oxidative stress to B. vulgatus in vitro. a ROS gating strategies. b The representative flow cytometry plots of DCFDA staining. Co-incubation of B. vulgatus with Blastocystis ST4 displayed significant higher DCFDA content indicating the presence of increased cellular ROS

Fig. 4
figure 4

Oxidoreductase gene expression of B. vulgatus when incubated with Blastocystis ST4-WR1 and ST4-WR2

Blastocystis ST4 protects intestinal epithelial barrier in vitro

The intestinal barrier protects intestinal cells from opportunistic pathogens in the lumen, which, when compromised, plays a key role in the development of inflammatory bowel diseases [21]. We explored the effect of Blastocystis ST4 and B. vulgatus on the intestinal epithelial barrier in vitro. ST4-WR1 and ST4-WR2 were individually incubated with B. vulgatus apically onto HT-29 cell monolayers differentiated on transwell inserts. TEER measurements showed that neither ST4-WR1 nor ST4-WR2 changed the epithelial barrier significantly compared with that of the control, which is consistent with our previous study on Caco-2 cells [22]. In contrast, B. vulgatus exhibited a significant drop in epithelial resistance compared to the control. Interestingly, the epithelial resistance increased significantly when ST4-WR1 and ST4-WR2 were co-cultured with B. vulgatus (Fig. 5a). In order to confirm the ST4-mediated protection of the epithelial barrier suggested by an increase in TEER, the flux assay was performed by measuring the flux of FITC across the intestinal epithelial barrier from the apical to the basolateral compartment. As expected, a significant increase in epithelial permeability was observed upon exposure to B. vulgatus (Fig. 5b), while the number of reporter molecules decreased significantly when co-cultured with ST4-WR1 and ST4-WR2. Altogether, both assays suggested that Blastocystis ST4 can reduce the damage mediated by B. vulgatus on the permeability of epithelial cells in vitro.

Fig. 5
figure 5

Bacteroides vulgatus disrupts the integrity of the epithelial barrier, while co-incubation with Blastocystis ST4 prevented the disruption of epithelial integrity (a, b)


Although Blastocystis has been proposed to be a causative agent of gastrointestinal and dermatological infections, its pathogenic potential and clinical significance remain unclear. Blastocystis ST7 decreases beneficial gut bacteria, leading to a dysbiotic state, and was the predominant subtype in diarrheal patients with C. difficile infection [3, 23], while the majority of microbiome studies report that Blastocystis is associated with higher bacterial diversity and can colonize the human gut for a long time without causing symptoms [5, 6, 10, 24]. Previous reports have reported on the mutualistic relationship between Blastocystis and gut commensal bacteria in vitro [3, 25]. The number of Blastocystis (ST3 and ST7) cells was higher in the presence of intestinal representative bacteria than in Blastocystis-only culture [3, 25]. Here we reported a consistent result in that both ST4-WR1 and ST4-WR2 showed higher Blastocystis cells count when co-incubated with intestinal bacteria. The bacteria may produce secretory molecules or metabolites as a nutrient source for Blastocystis proliferation.

In this study, B. fragilis, B. longum, B. subtilis, B. vulgatus, E. coli, E. faecalis, and L. brevis were selected for the co-incubation assay as representative species of the gut microbiota [26,27,28,29]. Among these, L. brevis and B. longum are well-known probiotic species that have anti-inflammatory properties [30, 31]. Lim et al. reported that the mixture of B. longum CH57 and L. brevis CH23 ameliorated colitis in mice by inhibiting macrophage activation and restoring the Th17/Treg balance [32]. Escherichia coli, E. faecalis, B. subtilis, and B. fragilis are important commensal gut bacteria, which play an important role in human nutrition and health by promoting carbohydrate metabolism, preventing pathogen colonization, and maintaining intestinal immune homeostasis [33]. It should be noted that B. fragilis is only a minor component of normal fecal flora, but is more often isolated during infection than the species representing a higher percentage of normal fecal isolates, such as B. vulgatus and B. thetaiotaomicron, that can be considered as commensals [34]. Bacteroides vulgatus, a Gram-negative obligate anaerobe, is linked to higher levels of intestinal inflammation and can cause colitis in mouse models and humans [35,36,37]. Notably, we mostly observed higher bacterial CFU counts when gut commensal bacteria were co-incubated with Blastocystis. The higher bacterial CFU count may be due to bacteria breaking down dead cells from Blastocystis or existing bacterial cells to obtain nutrients during Blastocystis bacteria co-incubation.

Nonetheless, a significant decrease in CFU count was observed in B. vulgatus after co-incubation with Blastocystis ST4-WR1. We further explored the underlying mechanism of Blastocystis inhibiting B. vulgatus, and our results suggested the presence of Blastocystis can cause oxidative stress on B. vulgatus. Indeed, oxidative stress can shift the microbial compositions by modulating the growth of specific bacterial taxa in the gut, especially exerting antimicrobial activity on strictly anaerobic bacteria [20]. Moreover, ROS can promote pathogen elimination by direct oxidative damage or by a variety of innate and adaptive mechanisms [38]. Defects in the pathogen’s antioxidant mechanism can convert highly virulent pathogens into ROS-sensitive pathogens, indicating that ROS directly damage microorganisms [39]. Additionally, the oxidative damage caused by ROS, such as lipid peroxidation, DNA strand breakage, base oxidation and deamination, and oxidation of methionine residues, can be directly tracked in microorganisms exposed to respiratory burst [40]. However, further clarification on the mechanism of Blastocystis causing high ROS in B. vulgatus is needed, and other mechanisms of Blastocystis-mediated decrease in B. vulgatus numbers need to be considered, such as whether pH changes caused by Blastocystis culture affect bacterial growth.

The barrier formed by the intestinal epithelium acts as the body’s first line preventing the entry of luminal opportunistic pathogens. Damage to epithelial barrier integrity is commonly associated with intestinal inflammatory diseases [41]. Bacteroides vulgatus can produce mucin-degrading enzymes such as glycosidase, sialidases, and neuraminidase, which can profoundly weaken the mucosal barrier function and exaggerate inflammation [42,43,44]. In vitro experiments demonstrated that B. vulgatus can invade colonic epithelial cells (SW-480 and HT-29) and activate the expression of pro-inflammatory cytokines [45]. In contrast, a recent study showed that B. vulgatus isolates could attenuate lipopolysaccharide (LPS)-induced IL-8 release from the HT-29 cell line [46], suggesting that different isolates of B. vulgatus have different pathological effects on colonic epithelial cells. It has also been determined that the expansion of B. vulgatus induces inflammatory gene expression and goblet cell dysfunction in nucleotide-binding oligomerization domain (NOD)-like receptor 2 (NOD2) knockout mice [35]. A recent study reported that the level of B. vulgatus is linked to higher levels of inflammation and microbial translocation during ART-suppressed HIV infection [47]. Interestingly, in vitro experiments revealed that Bifidobacterium (B. infantis 1222 and B. longum 7052) can suppress the growth of B. vulgatus after co-culture [48]. Our study showed, similarly, that co-incubation with Blastocystis ST4 can inhibit the ability of B. vulgatus to compromise the intestinal epithelial barrier, suggesting Blastocystis may play a similar probiotic role in vivo. Future studies should explore whether Blastocystis ST4 has similar beneficial effects on the gut microbiota in experimental mouse models and humans.

Blastocystis has enormous inter- or intra-genetic variation among subtypes, with different subtypes exhibiting distinct influences on gut microbiota and host immune responses [7, 8, 49]. For example, five strains of Blastocystis ST7 (B, C, E, G, and H) showed significant variations in cysteine protease activity, epithelial permeability, resistance to metronidazole, and enteroadhesion in a human colonic cell line [49]. It also has been determined that ST3 exhibits extreme intra-ST diversity [50], whereas ST4 genomes appear fairly conserved [50], and this could explain why the two strains of ST4 (WR1 and WR2) do not produce significantly distinct effects on B. vulgatus (in terms of growth, modification of TEER, permeability, and gene expression).


This is the first study to show the interactions between Blastocystis ST4 and several intestinal bacteria in vitro. We observed higher bacterial CFU counts when gut commensal bacteria were co-incubated with Blastocystis ST4, while the growth of B. vulgatus was inhibited. These results indicate that Blastocystis ST4 can interact with gut commensal bacteria, and lead to differential changes in the gut microbiota. Furthermore, co-incubation with Blastocystis ST4 was able to maintain the epithelial barrier in HT-29 monolayers, and ameliorate B. vulgatus-mediated barrier damage.

Availability of data and materials

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.



Quantitative polymerase chain reaction


Reactive oxygen species


Transepithelial electrical resistance


Small subunit ribosomal RNA


Recurrent Clostridioides difficile infections


Fecal microbiota transplantation


Flemish Gut Flora Project


American Gut Project


National University of Singapore


Iscove’s modified Dulbecco’s medium


American Type Culture Collection


Brain heart infusion


Colony-forming unit


Phosphate-buffered saline


Hank’s balanced salt solution




  1. Andersen LO, Stensvold CR. Blastocystis in health and disease: are we moving from a clinical to a public health perspective? J Clin Microbiol. 2016;54:524–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Clark CG, van der Giezen M, Alfellani MA, Stensvold CR. Recent developments in Blastocystis research. Adv Parasitol. 2013;82:1–32.

    Article  PubMed  Google Scholar 

  3. Yason JA, Liang YR, Png CW, Zhang Y, Tan KSW. Interactions between a pathogenic Blastocystis subtype and gut microbiota: in vitro and in vivo studies. Microbiome. 2019;7:30.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Céline N, Julien S, Bruno P, Christina NM, Ivan W, Amandine C, et al. Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS ONE. 2014;9:e111868.

    Article  Google Scholar 

  5. Audebert C, Even G, Cian A, Group BI, Loywick A, Merlin S, et al. Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota. Sci Rep. 2016;6:25255.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Tito RY, Chaffron S, Caenepeel C, Lima-Mendez G, Wang J, Vieira-Silva S, et al. Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota. Gut. 2019;68:1180–9.

    Article  CAS  PubMed  Google Scholar 

  7. Deng L, Wojciech L, Gascoigne NRJ, Peng G, Tan KSW. New insights into the interactions between Blastocystis, the gut microbiota, and host immunity. PLoS Pathog. 2021;17:e1009253.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Maloney JG, da Cunha MJR, Molokin A, Cury MC, Santin M. Next-generation sequencing reveals wide genetic diversity of Blastocystis subtypes in chickens including potentially zoonotic subtypes. Parasitol Res. 2021;120:2219–31.

    Article  PubMed  Google Scholar 

  9. Stensvold CR, Tan KSW, Clark CG. Blastocystis. Trends Parasitol. 2020;36:315–6.

    Article  PubMed  Google Scholar 

  10. Beghini F, Pasolli E, Truong TD, Putignani L, Cacciò SM, Segata N. Large-scale comparative metagenomics of Blastocystis, a common member of the human gut microbiome. ISME J. 2017;11:2848–63.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Onuoha ESU, Fagbenro-Beyioku AF, Clark CG. Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop. 2013;126:11–8.

    Article  PubMed  Google Scholar 

  12. Forsell J, Bengtsson-Palme J, Angelin M, Johansson A, Evengård B, Granlund M. The relation between Blastocystis and the intestinal microbiota in Swedish travellers. BMC Microbiol. 2017;17:231.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Nourrisson C, Scanzi J, Pereira B, NkoudMongo C, Wawrzyniak I, Cian A, et al. Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS ONE. 2014;9:e111868.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Terveer EM, van Gool T, Ooijevaar RE, Sanders I, Boeije-Koppenol E, Keller JJ, et al. Human transmission of Blastocystis by fecal microbiota transplantation without development of gastrointestinal symptoms in recipients. Clin Infect Dis. 2020;71:2630–6.

    Article  PubMed  Google Scholar 

  15. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human genetics shape the gut microbiome. Cell. 2014;159:789–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. McDonald D, Hyde E, Debelius JW, Morton JT, Gonzalez A, Ackermann G, et al. American Gut: an open platform for citizen science microbiome research. mSystems. 2018;3:e00031-e118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chen XQ, Singh M, Ho LC, Moe KT, Tan SW, Yap EH. A survey of Blastocystis sp. in rodents. Lab Anim Sci. 1997;47:91–4.

    CAS  PubMed  Google Scholar 

  18. Zweibaum A, Laburthe M, Grasset E, Louvard D. Use of cultured cell lines in studies of intestinal cell differentiation and function. Compr Physiol. p. 223–55.

  19. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24:981–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Weiss GA, Hennet T. Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci. 2017;74:2959–77.

    Article  CAS  PubMed  Google Scholar 

  21. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489–99.

    Article  CAS  PubMed  Google Scholar 

  22. Wu Z, Mirza H, Teo JD, Tan KS. Strain-dependent induction of human enterocyte apoptosis by Blastocystis disrupts epithelial barrier and ZO-1 organization in a caspase 3- and 9-dependent manner. BioMed Res Intern. 2014;2014:209163.

    Google Scholar 

  23. Deng L, Tay H, Peng G, Lee JWJ, Tan KSW. Prevalence and molecular subtyping of Blastocystis in patients with Clostridium difficile infection. Singapore Parasi Vect. 2021;14:277.

    Article  CAS  Google Scholar 

  24. Gabrielli S, Furzi F, Fontanelli Sulekova L, Taliani G, Mattiucci S. Occurrence of Blastocystis-subtypes in patients from Italy revealed association of ST3 with a healthy gut microbiota. Parasite Epidemiol Control. 2020;9:e00134.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lepczyńska M, Dzika E. The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on Blastocystis ST3. Gut Pathog. 2019;11:6.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Holt JF, Kiedrowski MR, Frank KL, Du J, Guan C, Broderick NA, et al. Enterococcus faecalis 6-phosphogluconolactonase is required for both commensal and pathogenic interactions with Manduca sexta. Infect Immun. 2015;83:396–404.

    Article  PubMed  Google Scholar 

  27. Hong HA, Khaneja R, Tam NM, Cazzato A, Tan S, Urdaci M, et al. Bacillus subtilis isolated from the human gastrointestinal tract. Res Microbiol. 2009;160:134–43.

    Article  CAS  PubMed  Google Scholar 

  28. Leimbach A, Hacker J, Dobrindt U. E. coli as an all-rounder: the thin line between commensalism and pathogenicity. Curr Top Microbiol Immunol. 2013;358:3–32.

    PubMed  Google Scholar 

  29. Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA. 2002;99:14422–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Plaza-Díaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A. Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients. 2017;9:555.

    Article  PubMed Central  Google Scholar 

  31. Sales-Campos H, Soares SC, Oliveira CJF. An introduction of the role of probiotics in human infections and autoimmune diseases. Crit Rev Microbiol. 2019;45:413–32.

    Article  PubMed  Google Scholar 

  32. Lim S-M, Jeong J-J, Jang S-E, Han MJ, Kim D-H. A mixture of the probiotic strains Bifidobacterium longum CH57 and Lactobacillus brevis CH23 ameliorates colitis in mice by inhibiting macrophage activation and restoring the Th17/Treg balance. J Funct Food. 2016;27:295–309.

    Article  CAS  Google Scholar 

  33. Kelly D, Conway S, Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. 2005;26:326–33.

    Article  CAS  PubMed  Google Scholar 

  34. Maskell JP. The pathogenicity of Bacteroides fragilis and related species estimated by intracutaneous infection in the guinea-pig. J Med Microbiol. 1981;14:131–40.

    Article  CAS  PubMed  Google Scholar 

  35. Ramanan D, Tang MS, Bowcutt R, Loke P, Cadwell K. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity. 2014;41:311–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microb. 2011;9:390–403.

    Article  CAS  Google Scholar 

  37. Bamba T, Matsuda H, Endo M, Fujiyama Y. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J Gastroenterol. 1995;30:45–7.

    PubMed  Google Scholar 

  38. Paiva CN, Bozza MT. Are reactive oxygen species always detrimental to pathogens? Antioxid Redox Signal. 2014;20:1000–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. O’Rourke EJ, Chevalier C, Pinto AV, Thiberge JM, Ielpi L, Labigne A, et al. Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonization. Proc Natl Acad Sci USA. 2003;100:2789–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Praticò D. In vivo measurement of the redox state. Lipids. 2001;36:S45–7.

    Article  PubMed  Google Scholar 

  41. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799–809.

    Article  CAS  PubMed  Google Scholar 

  42. Ruseler-van Embden JG, van der Helm R, van Lieshout LM. Degradation of intestinal glycoproteins by Bacteroides vulgatus. FEMS Microbiol Lett. 1989;49:37–41.

    Article  CAS  PubMed  Google Scholar 

  43. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM, Dekker J. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microb. 2010;1:254–68.

    Article  Google Scholar 

  44. Huang YL, Chassard C, Hausmann M, von Itzstein M, Hennet T. Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. Nature Comm. 2015;6:8141.

    Article  CAS  Google Scholar 

  45. Ohkusa T, Yoshida T, Sato N, Watanabe S, Tajiri H, Okayasu I. Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J Med Microbiol. 2009;58:535–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Hiippala K, Kainulainen V, Suutarinen M, Heini T, Bowers JR, Jasso-Selles D, et al. Isolation of anti-inflammatory and epithelium reinforcing bacteroides and Parabacteroides spp. from a healthy fecal donor. Nutrients. 2020;12:935.

    Article  CAS  PubMed Central  Google Scholar 

  47. Giron LB, Tanes CE, Schleimann MH, Engen PA, Mattei LM, Anzurez A, et al. Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection. Mucosal Immunol. 2020;13:753–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Shiba T, Aiba Y, Ishikawa H, Ushiyama A, Takagi A, Mine T, et al. The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol Immunol. 2003;47:371–8.

    Article  CAS  PubMed  Google Scholar 

  49. Wu Z, Mirza H, Tan KS. Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7. PLoS Negl Trop Dis. 2014;8:e2885.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Stensvold CR, Alfellani M, Clark CG. Levels of genetic diversity vary dramatically between Blastocystis subtypes. Infect Genet Evol. 2012;12:263–73.

    Article  PubMed  Google Scholar 

Download references


We would like to thank Wuyou Wang for critical editing. We thank Dr. Tong Jiexin for her technical guidance on flow cytometry. We thank Dr. John Anthony Yason for his technical guidance on co-culture.


This work was funded by MOE Tier-1 Grant (R-571-000-037-114).

Author information

Authors and Affiliations



KSWT and LD conceived and designed the study. Experiments were performed by LD. Data were analyzed by LD. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Kevin S. W. Tan.

Ethics declarations

Ethics approval and consent to participate

Isolates WR1 and WR2 were originally isolated from healthy Wistar rats during an animal survey in the early 1990s, before the Institutional Animal Care and Use Committee was established at NUS.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

qPCR primers used in this study.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, L., Tan, K.S.W. Interactions between Blastocystis subtype ST4 and gut microbiota in vitro. Parasites Vectors 15, 80 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: